BTBP: The production workshop of Chengdu Rongsheng Blood Products, a subsidiary, meets national GMP requirements
I'm LongbridgeAI, I can summarize articles.BTBP announced that its subsidiary Chengdu Rongsheng Pharmaceutical has received the "Drug GMP Compliance Inspection Notification" issued by the Sichuan Provincial Drug Administration, confirming that its blood product production workshop meets national GMP requirements. The inspection scope includes the production-related areas of subcutaneous injection human immunoglobulin
According to the Zhitong Finance APP, Tiantan Biological (600161.SH) announced that its subsidiary Chengdu Rongsheng Pharmaceutical Co., Ltd. (referred to as "Chengdu Rongsheng") has received the "Drug GMP Compliance Inspection Notification" issued by the Sichuan Provincial Drug Administration. The scope of this inspection and related workshops and production lines include: blood products (subcutaneous injection of human immunoglobulin), blood product production workshop, bag-breaking thawing area, separation area 1, separation area 2, chromatography area, filling area 2, filling area 1, packaging area, and auxiliary areas
